老年头颈癌患者相关预后因素:EGeSOR临床试验
本研究为EGeSOR随机对照试验的二次分析,纳入475例65岁及以上、适合根治或姑息治疗的头颈癌患者,随机接受老年评估驱动干预或标准治疗,随访24个月。两组2年总生存率无组间差异(HR 0.82 [95%CI 0.60;1.12],p=0.208)。女性为全因死亡的保护因素,年龄较大和合并症数量与较差的2年总生存相关,衰弱风险(G8评分)与2年总生存无关。
要点
- 两组2年总生存率无组间差异(HR 0.82 [95%CI 0.60;1.12],p=0.208)。
- 女性为全因死亡的保护因素(p=0.008和p=0.003)。
- 年龄较大和合并症数量与较差的2年总生存相关。
核心结论
- 研究结果突出了若干患者相关预后因素,在做出治疗决策时不应仅考虑实足年龄和肿瘤相关变量。
研究设计与样本
- 本研究为在法国2013年至2018年间开展的EGeSOR随机对照试验的二次分析。
- 纳入475例65岁及以上、适合根治或姑息治疗的头颈癌患者,随机接受老年评估及结果驱动干预和随访(干预组)或标准治疗(对照组),随访24个月。
主要发现
- 两组2年总生存率无组间差异(HR 0.82 [95%CI 0.60;1.12],p=0.208)。
- 在两个多变量模型中,女性为全因死亡的保护因素(p=0.008和p=0.003)。
- 年龄较大(p<0.001)和合并症数量与较差的2年总生存相关。
- 衰弱风险(G8评分)与2年总生存无关。
- 低自主性(工具性日常生活活动能力评分<8)、行动能力差(单腿站立测试结果<5秒)、营养状况异常(微型营养评估评分异常)和认知状态差(简易精神状态检查评分<24)与较差的2年总生存相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Due to its anatomic site, the treatment of head and neck cancer (HNC) significantly affects activities of daily living. Clinical heterogeneity and accelerated aging in older adults make it crucial to identify patient-related, prognostic factors. The objective of the present study was to assess the prognostic value of patient-related factors for 2-year overall survival (OS) in older adults with HNC, after adjustment for tumor-related factors. METHODS: This was a secondary analysis of the EGeSOR randomized, controlled trial conducted in France between 2013 and 2018. Patients with HNC aged 65 or over and who were candidates for either curative or palliative treatment were randomized to receive a geriatric assessment with result-driven interventions and follow-up (the intervention group) or the standard of care (the control group) and followed up for 24 months. The primary outcome was two-year OS. RESULTS: 475 patients were included. There was no intergroup difference in the 2-year OS rate (hazard ratio (HR) [95 %CI] = 0.82 [0.60;1.12], p = 0.208). In two multivariable models, female sex was a protective factor against all-cause death (p = 0.008 and p = 0.003). Older age (p < 0.001) and the number of comorbidities were associated with poor 2-year OS. The frailty risk (G8 score) was not associated with 2-year OS. When considering the geriatric assessment variables, low autonomy (an instrumental activities of daily living score <8), poor mobility (a one-leg standing test result <5 s), nutritional status (an abnormal Mini Nutritional Assessment score) and cognitive status (a Mini Mental State Examination score <24) were associated with poor 2-year OS. CONCLUSION: The study's results highlighted several patient-related, prognostic factors. Chronological age and tumor-related variables should not be the only factors taken into account when making treatment decisions.
引用
- Lafont C, Paillaud E, Jean C, et al. Patient-related prognostic factors in older adults with head and neck cancer: The EGeSOR clinical trial. Eur J Cancer. 2025. PMID: 40684734. doi:10.1016/j.ejca.2025.115630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。